Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancerAthanassios Argiris, Robert L. Ferris, Dwight E. Heron et al.|Annals of Oncology|2016Cited by 49
Phase I trial of cetuximab, intensity modulated radiotherapy (IMRT), and ipilimumab in previously untreated, locally advanced head and neck squamous cell carcinoma (PULA HNSCC)Julie E. Bauman, Dwight E. Heron, Robert L. Ferris et al.|Annals of Oncology|2016Cited by 8